Abstract
purpose. Indocyanine green (ICG) and trypan blue have been advocated as vital stains for use during macular surgery. The safety of these agents was tested using a cell culture model.
methods. Human retinal pigment epithelium (RPE) and Müller cell lines were exposed to ICG over a range of concentrations up to 0.5%, and trypan blue up to 0.2%. Cells were exposed to each dye for 5, 15, or 30 minutes, rinsed, and incubated 24 hours. Cell viability was measured using a mitochondrial dehydrogenase-assay and fluorescent live–dead probe. Experiments were repeated using 0.5% and 1% ICG and 0.06% and 0.12% trypan blue, with follow-up at 0, 1, 5, and 15 days. ICG experiments were repeated in the presence of illumination from a xenon light-source channeled through a surgical endolight, and using reduced osmolarity solutions of 0.1%, 0.5%, and 1% (185 vs. 275 mOsM).
results. There was no clear relationship between cell viability and the concentration of the agent or duration of follow-up, except in RPE cells exposed to 1% ICG. These showed a linear (R 2 0.9952) decline in viability with time, with a significant reduction by day 15 (P = 0.016). RPE cells exposed to ICG and illumination were not significantly different from the negative control, but when illumination was combined with low osmolarity, viability was reduced (P = 0.0016). ICG and illumination reduced Müller cell viability (P < 0.0001 for both 185 and 275 mOsM). Müller cells incubated with 185 mOsM 1% ICG showed a significant reduction in viability (P < 0.0001) not seen with the 185 mOsM 0.5% or 0.1% solutions or in the low-osmolarity RPE groups.
conclusions. The combination of exposure to 0.5% ICG and the newer endoillumination light-sources can damage cultured Müller cells. Although the preparations of ICG most commonly used clinically did not produce significant damage, relatively small changes in ICG osmolarity and concentration did. This suggests that safety margins are not large. Trypan blue is safe in a cell culture model.
Trypan blue and indocyanine green (ICG) have been advocated as vital stains to enhance visualization of optically clear tissue during macular surgery.
1 2 3 4 5 6 7 8 By selectively staining ocular tissue,
8 9 10 these agents make structures such as the inner limiting membrane (ILM)
1 3 4 5 6 8 10 11 12 13 and epiretinal membranes
14 more evident to the surgeon. Although these chromophores are useful surgical tools, there has been a debate regarding the safety of ICG
11 12 13 15 16 17 18 19 20 21 22 and its effect on the retinal pigment epithelium (RPE).
12 15 23 24 Clinical studies have suggested functional visual loss after its use,
25 26 and many investigators have called for more safety testing.
11 12 13 15 18 21 27
The purpose of this study was to undertake safety testing of ICG and trypan blue using a cell culture model. Experiments were also undertaken to investigate reports that ICG and endoillumination combine to affect cell viability adversely,
21 23 28 as does the combination of ICG and low osmolarity.
24 Unlike previous studies, experiments were undertaken on both RPE and Müller cell lines. This may be important, as studies suggest that it is not only the RPE, but also the neuroretinal elements that may be damaged by ICG.
19 In particular, profound structural changes have been shown in Müller cells after ICG-assisted macular surgery in cadaveric eyes.
21 Given the proximity of the Müller cell end feet to the vitreous surface and their integral association with the ILM, these cells are potentially vulnerable to damage from any neurotoxic agent that binds to the ILM or epiretinal membranes.
A human RPE cell line (ARPE-19, passage 23; American Type Culture Collection, Manassas, VA) was cultured using established techniques.
29 Cells were cultured in Ham’s F-10 medium (pH 7.4; Sigma-Aldrich, Poole, UK), supplemented with 2 mM glutamine, 25 mM HEPES, 10 IU/mL penicillin, 10 μg/mL streptomycin, and 15% heat-inactivated fetal calf serum (Sigma-Aldrich). Cells were grown to confluence in an incubator with a humidified atmosphere of 5% CO
2 95% air at 37°C and kept in a confluent state for 24 to 48 hours before subculture. Cells were trypsinized and seeded at 5 × 10
4 cells/well into 96-well flat-bottomed plates (TPP, Trasadingen, Switzerland) and 16-well chamber slides (Nunc Inc., Naperville, IL).
Once cells reached confluence, the growth medium was replaced with 100 μL of the test agent. The concentrations selected were designed to encompass those used clinically. Serial dilutions were prepared to simulate the situation that occurs when the vital stain is diluted into the vitreous volume and to look for dose-related effects. ICG was prepared as described previously.
1 30 Twenty-five milligrams of medical grade ICG (BD Biosciences, Cockeysville, MD) was dissolved in 0.5 mL distilled water. This was mixed until fully dissolved, then combined with 4.5 mL of a balanced saline solution (BSS; Alcon, Hemel Hempstead, UK) to produce a 0.5% (5 mg/mL) solution. This preparation was diluted with BSS to provide solutions with a final concentration of 0.5%, 0.25%, 0.125%, 0.0625%, and 0.03125% (
n = 7 for each). Trypan blue was dissolved in BSS to give a final concentration of 0.2%, 0.1%, 0.05%, 0.025%, and 0.0125% (n = 8 for each). The osmolarity of each preparation was measured using a micro-osmometer (Advanced Instruments, Needham Heights, MA) and is shown in
Table 1 . Exposure times were 5, 15, and 30 minutes for each concentration of agent. After this interval, the wells were rinsed three times with BSS and the growth medium was replaced. Cells were incubated for 24 hours and then viability was assessed.
The experiments using cells exposed to 0.5% ICG for 5 minutes were repeated with irradiating white light provided by a standard, wide-angle, fiber-optic, endoillumination light-pipe (Alcon Laboratory, Ltd., Herts, UK). After exposure to ICG, wells were rinsed only once with BSS so that the monolayers were still stained with ICG. Each well was individually illuminated with the endolight powered by a medical 300-W xenon light-source (Keeler Instruments, Broomall, PA) set on full power. A xenon light source was selected over the more commonly used halogen light source, as it provided more stimulus for ICG excitation and more chance of detecting ICG-mediated phototoxicity.
31 Xenon light sources have recently been made available for use with some of the more commonly used vitrectors. The total lamp output was 5000 lumens (manufacturer’s data) and this was channeled into a fiber optic cable without the interposition of barrier filters. The fiber optic cable had an illumination transmittance of 45% and an angular spread of 8 numeric aperture (NA; manufacturer’s data). The wells were filled with BSS and the light-pipe immersed into each well and held for 1 minute, 5 mm above the cell monolayer (
n = 12–24 for each group). After illumination the BSS was replaced with growth medium and cell viability was measured at 24 hours. Experiments were repeated on cells that had undergone illumination after incubation with BSS, and ICG but no illumination.
To assess the potential for delayed toxicity, experiments were repeated with cells exposed to 0.5% and 1% ICG, and 0.06% and 0.12% trypan blue for five minutes each, with cell viability measured at days 0, 1, 5, and 15 (n = 24 for each concentration and time). The 1% ICG solution was prepared as per the 0.5% solution, except that 50 mg of ICG was dissolved into 0.5 mL of water for injection, instead of 25 mg. The osmolarity of this preparation was 282 mOsM.
Cell viability was estimated using an MTT (3-(4 to 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (Sigma-Aldrich). Cells were incubated at 37°C with 100 μL of filtered, 5 mg/mL MTT. After 4 hours, 100 μL of dimethyl sulfoxide (Sigma-Aldrich) was added to lyse the cells and solubilize the formazan reaction product. After 30 minutes, the plates were read in a microplate reader (MR5000; Dynatech, Guernsey, UK) at a test wavelength of 570 nm and reference wavelength of 630 nm.
A qualitative assessment of cell viability was undertaken using a live–dead probe (Molecular Probes Inc., Eugene, OR). Live cells were identified using calcein-AM (CAM) and dead cells using ethidium homodimer (EH)-1. Titration experiments were conducted to determine the ideal concentration of reagents, as recommended by the manufacturer. Cells were viewed on confocal (LSM 510; Carl Zeiss Meditec, Jena, Germany) and fluorescence (Leitz, Wetzlar, Germany) microscopes.
To assess the effect of ICG in combination with low osmolarity, MTT assays were repeated on cells exposed to ICG solutions with reduced osmolarity. Instead of dissolving ICG into 0.5 mL of water and then 4.5 mL of BSS, 0.1%, 0.5%, and 1% solutions were prepared by dissolving ICG into 2 mL water and 3 mL BSS to produce a solution of approximately 185 mOsM (range, 182–191; mean, 186 ± 4.5 SD). Cells were exposed to the test agent for 5 minutes, and viability was assessed at 24 hours (n = 24–32 for each group). Experiments using low osmolarity 0.5% ICG were repeated in the presence of endoillumination (n = 12).
Control experiments were undertaken to determine the effect of hypo-osmotic solutions on cell viability. Cells were incubated with the test solution for 5 minutes, and viability was assessed at 24 hours with the MTT assay. Solutions of various osmolarities were obtained by mixing distilled water with BSS, as occurs in the preparation of ICG. These included a mix of 2 mL water and 3 mL BSS (osmolarity, 181 mOsM); 1 mL water, 4 mL BSS (242 mOsM); 0.5 water, 4.5 mL BSS (272 mOsM); 0.25 mL water, 4.75 mL BSS (286 mOsM); 0.125 water, 4.875 mL BSS (294 mOsM), and 0.063 mL water, 4.937 mL BSS (298 mOsM; n = 5 to 10 for each group). Results were compared with those from cells incubated with BSS alone.
Negative (live-cell) controls were provided by incubating with BSS instead of the test agent. Dead cells were obtained by exposing cells to 30% methanol. For each test agent, the results obtained from the microplate reader were expressed as a percentage of the negative control. Using this system, values under 100% indicated that the concentration of formazan reaction product was less than that of the negative control, representing a reduced index of cell viability.
Experiments were repeated using a Müller cell line (passage 57; gift of G. Astrid Limb, The Institute of Ophthalmology, London, UK) grown in Dulbecco’s modified Eagles medium containing
l-Glutamax 1 (Invitrogen-Gibco, Paisley, Scotland, UK), supplemented with 2 mM glutamine, 10 IU/mL penicillin, 10 μg/mL streptomycin, and 10% heat-inactivated fetal calf serum (Sigma-Aldrich). The isolation and characterization of these cells is presented elsewhere.
32 Briefly, a spontaneously immortalized cell line was obtained from a 68-year-old female donor. Retina was vigorously pipetted and then trypsinized. Cells were filtered through a stainless-steel sieve, washed, and then grown to confluence. Müller cells were identified using phase-contrast microscopy and by immunostaining for glutamate synthetase, glial fibrillary acidic protein, α-smooth muscle actin, vimentin, cellular retinaldehyde binding protein, and epidermal growth factor receptor. Additional tests including electron microscopy and electrophysiology all confirmed the origin of these cells and are shown in the cited reference.
Müller cells were passaged by rinsing them in Hank’s-buffered saline solution (Sigma-Aldrich) followed by immersion in one-fourth growing volume of 10× trypsin/EDTA solution (Sigma-Aldrich) for up to 5 minutes. Fresh medium was added so that the medium was returned to its original volume. The cells now in suspension were then split (usually 1:3 or 1:5, depending on cell density) to maintain their density at 60% to 80% confluence.
As ICG and trypan blue were both chromophores in the blue-green region of the visible spectrum, experiments were conducted to determine whether these dyes interfered with the MTT assay of the blue formazan reaction product. Cells that had been incubated with trypan blue or ICG and then rinsed in the usual manner were placed into the microplate reader, without the addition of MTT. The optical density of these cells was compared with those incubated with BSS (n = 24).
As noted by other investigators,
33 we did not have any difficulty discriminating the round nucleolar staining pattern of dead cells labeled with EH-1 from the granular autofluorescence that may occur with higher concentrations of trypan blue.
Experiments were conducted to determine whether the laboratory grade trypan blue used in the above experiments produced different effects on cell viability to the medical grade preparation used clinically. The laboratory grade preparation was chosen as it allowed a wider range of concentrations than the medical grade preparation that came premade as a 0.06% or 0.15% solution. Hence, concentrations higher than this could not have easily been prepared. Cells were incubated with 0.06% medical (Dorc, Zuidland, The Netherlands) or laboratory grade trypan blue for 5 minutes, and cell viability was measured at 24 hours, as in previous experiments (n = 24).
Cells were defined as having reduced viability if the mean of at least three experiments using the MTT assay fell below two standard deviations of the negative control. Graphs showing the SD of the negative control show the SD for that experiment, rather than the smaller SD from the overall pooled data. Group comparisons were made using the independent t-test, with Welch correction where standard deviations differed significantly. Nonparametric (Mann–Whitney) tests were used if assumption tests (Kolmogorov-Smirnov) indicated that the groups were not sampled from populations with a Gaussian distribution. P ≤ 0.05 was considered significant. EH-1/CAM was used as an independent, qualitative test without statistical comparison.
Interaction of Indocyanine Green and Osmolarity.
Delayed Cell Damage.
Interaction of ICG and Illumination.
Strengths and Weaknesses.
In summary, this study found no evidence of cell damage in human RPE and Müller cell cultures incubated with trypan blue and ICG in the doses used clinically. However, glial cells were damaged when exposed to 0.5% ICG and xenon endoillumination. When concentrations were increased and osmolarities reduced beyond those used clinically, then cell damage was evident in both RPE and glial cells delayed RPE toxicity occurred with a 1% ICG solution, acute glial toxicity with low osmolarity 1% ICG. Glial cell viability was reduced when high-concentration ICG was combined with low osmolarity or light exposure. RPE cells were less vulnerable to low-osmolarity preparations, and these combinations did not significantly reduce viability. However, the combination of all three (high concentration, low osmolarity ICG, and illumination) resulted in significant reductions in viability. These findings can be used to draw three main conclusions. First, relatively small changes in ICG osmolarity and concentration may result in cell damage, suggesting that safety margins are not large. Second, 0.5% ICG may produce glial damage if combined with the newly introduced xenon light sources. Last, trypan blue is safe in a cell culture model.
Presented in part at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 2003.
This work was part of a doctorate in philosophy (TLJ).
Supported by research grants from Allerton Trust; Special Trustees of Guys and St. Thomas Hospitals; and the German Research Council Grant DFGHi758/1-1.
Submitted for publication February 18, 2004; revised March 20, 2004; accepted March 22, 2004.
Disclosure:
T.L. Jackson, Keeler Instruments (F);
J. Hillenkamp, None;
B.C. Knight, None;
J.-J. Zhang, None;
D. Thomas, None;
M.R. Stanford, None;
J. Marshall, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Timothy L. Jackson, Academic Department of Ophthalmology, The Rayne Institute, St. Thomas’ Hospital, London SE1 7EH, UK;
tim.jackson@nhs.net.
Table 1. Osmolarity of Preparations Used in the Study
Table 1. Osmolarity of Preparations Used in the Study
Agent (% weight/volume) | Osmolarity (mOsM ± SD) |
Trypan blue | |
0.2 | 329 ± 2.3 |
0.1 | 319 ± 1.0 |
0.05 | 314 ± 1.5 |
0.025 | 310 ± 1.7 |
0.0125 | 308 ± 0.6 |
Indocyanine green | |
1.0 | 282 ± 1.0 |
0.5 | 276 ± 0.6 |
0.25 | 287 ± 0.6 |
0.125 | 294 ± 0.6 |
0.0625 | 300 ± 1.0 |
0.0313 | 301 ± 0.6 |
Balanced saline solution | 302 ± 0.6 |
Water for injection | 0 ± 0.0 |
The authors thank Austin El Osta and Paul Constable for assistance with cell culturing.
Da Mata AP, Burk SB, Riemann CD, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology
. 2001;108:1187–1192.
[CrossRef] [PubMed]Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol
. 2003;87:216–219.
[CrossRef] [PubMed]Kusaka S, Hayashi N, Ohji M, Hayashi A, Kamei M, Tano Y. Indocyanine green facilitates removal of epiretinal and internal limiting membranes in myopic eyes with retinal detachment. Am J Ophthalmol
. 2001;131:388–390.
[CrossRef] [PubMed]Kadonosono K, Yazama F, Itoh N, et al. Treatment of retinal detachment resulting from myopic macular hole with internal limiting membrane removal. Am J Ophthalmol
. 2001;131:203–207.
[CrossRef] [PubMed]Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol
. 2000;118:1116–1118.
[CrossRef] [PubMed]Eshita T, Ishida S, Shinoda K, et al. Indocyanine green can distinguish posterior vitreous cortex from internal limiting membrane during vitrectomy with removal of epiretinal membrane. Retina
. 2002;22:104–106.
[CrossRef] [PubMed]Foster RE, Petersen MR, Da Mata AP, Burk SE, Rosa RHJ, Riemann CD. Negative indocyanine green staining of epiretinal membranes. Retina
. 2002;22:106–108.
[CrossRef] [PubMed]Kwok AK, Li WW, Pang CP, et al. Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol
. 2001;132:178–183.
[CrossRef] [PubMed]Burk SE, Da Mata AP, Snyder ME, Rosa R-HJ, Foster RE. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology
. 2000;107:2010–2014.
[CrossRef] [PubMed]Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol
. 2001;131:387–388.
[CrossRef] [PubMed]Weinberger AWA, Kirchhof B, Mazinani BE, Schrage NF. Persistent indocyanine green (ICG) fluorescence 6 weeks after intraocular ICG administration for macular hole surgery. Graefe’s Arch Clin Exp Ophthalmol
. 2001;239:388–390.
[CrossRef] Engelbrecht NE, Freeman J, Sternberg P, Jr, et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol. 2002;133:1394.
Haritoglou C, Gandorfer A, Gass CA, Kampik A. Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol
. 2002;133:587–588.
[CrossRef] [PubMed]Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, Van Lommel A, Melles GRJ, Stalmans P. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol
. 2002;120:141–144.
[CrossRef] [PubMed]Gandorfer A, Haritoglou C, Gass CA, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol
. 2001;132:431–433.
[CrossRef] [PubMed]Weinberger AW, Schlossmacher B, Dahlke C, Hermel M, Kirchhof B, Schrage NF. Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery–a follow-up study. Graefe’s Arch Clin Exp Ophthalmol
. 2002;240:913–917.
[CrossRef] Kwok AK, Lai TY, Man-Chan W, Woo DC. Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol
. 2003;87:71–74.
[CrossRef] [PubMed]Schechter RJ. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol. 2002;134:150–151.
Enaida H, Sakamoto T, Hisatomi T, Goto Y, Ishibashi T. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefe’s Arch Clin Exp Ophthalmol
. 2002;240:209–213.
[CrossRef] Haritoglou C, Gass CA, Gandorfer A, Kampik A. ICG-assisted peeling of the retinal ILM. Ophthalmology
. 2002;109:1039.
[CrossRef] Gandorfer A, Haritoglou C, Gandorfer A, Kampik A. Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci
. 2003;44:316–323.
[CrossRef] [PubMed]Kampik A, Sternberg P. Indocyanine green in vitreomacular surgery: (why) is it a problem?. Am J Ophthalmol
. 2003;136:527–529.
[CrossRef] [PubMed]Sippy BD, Engelbrecht NE, Hubbard GB, et al. Indocyanine green effect on cultured human retinal pigment epithelial cells: implications for macular hole surgery. Am J Ophthalmol
. 2001;132:433–435.
[CrossRef] [PubMed]Stalmans P, Van Aken EH, Veckeneer M, Feron EJ, Stalmans I. Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol
. 2002;134:282–285.
[CrossRef] [PubMed]Uemura A, Kanda S, Sakamoto Y, Kita H. Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol
. 2003;136:252–257.
[CrossRef] [PubMed]Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol
. 2002;134:836–841.
[CrossRef] [PubMed]Kwok AK, Lai TY, Yew DT, Li WW. Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol
. 2003;136:223–330.
[CrossRef] [PubMed]Yam HF, Kwok AK, Chan KP, et al. Effect of indocyanine green and illumination on gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci
. 2003;44:370–377.
[CrossRef] [PubMed]Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, A human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res
. 1996;62:155–169.
[CrossRef] [PubMed]Horiguchi M, Miyake K, Ohta I, Ito Y. Staining of the lens capsule for circular continuous capsulorrhexis in eyes with white cataract. Arch Ophthalmol
. 1998;116:535–537.
[CrossRef] [PubMed]Marshall J. Vision and Visual Dysfunction. 1991;54–66. Macmillan Press London.
Limb GA, Salt TE, Munroe PMG, Moss SE, Khaw PT. In vitro characterization of a spontaneously immortalized human Müller cell line. Invest Ophthalmol Vis Sci
. 2002;43:864–869.
[PubMed]Stalmans P, Van Aken EH, Melles G, Veckeneer M, Feron EJ, Stalmans I. Trypan blue not toxic for retinal pigment epithelium in vitro. Am J Ophthalmol
. 2003;135:234–236.
[CrossRef] [PubMed]Lillie RD. H. J. Conn’s Biological Stains. 1977; 9th ed. Williams and Wilkins Baltimore.
Perrier M, Sebag M. Epiretinal membrane surgery assisted by trypan blue. Am J Ophthalmol
. 2003;135:909–911.
[CrossRef] [PubMed]Perrier M, Sebag M. Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery. Am J Ophthalmol
. 2003;135:903–905.
[CrossRef] [PubMed]Funahashi T, Kondo K, Kimura M. The vital staining of the eye. Acta Soc Ophthalmol Jpn. 1980;84:1826–1880.
Melles G RJ, de Waard PWT, Pameyer JH, Beekhuis WH. Trypan blue capsule staining to visualize the capsulorrhexis in cataract surgery. J Cataract Refract Surg
. 1999;25:7–9.
[CrossRef] [PubMed]Veckeneer M, van Overdam K, Monzer J, et al. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol
. 2001;239:698–704.
[CrossRef] [PubMed]Ho JD, Tsai RJ, Chen SN, Chen HC. Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol
. 2003;135:258.
[CrossRef] [PubMed]Spaide RF. Persistent intraocular indocyanine green staining after macular hole surgery. Retina
. 2002;22:637–639.
[CrossRef] [PubMed]Hirata A, Inomata Y, Kawaji T, Tanihara H. Persistent subretinal indocyanine green induces retinal pigment epithelium atrophy. Am J Ophthalmol
. 2003;136:353–355.
[CrossRef] [PubMed]Tadayoni R, Paques M, Girmens JF, Massin P, Gaudric A. Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology
. 2003;110:604–608.
[CrossRef] [PubMed]Horiguchi M, Nagata S, Yamamoto N, Kojima Y, Shimada Y. Kinetics of indocyanine green dye after intraocular surgeries using indocyanine green staining. Arch Ophthalmol
. 2003;121:327–331.
[CrossRef] [PubMed]Ciardella AP, Schiff W, Barile G, et al. Persistent indocyanine green fluorescence after vitrectomy for macular hole. Am J Ophthalmol
. 2003;136:174–177.
[CrossRef] [PubMed]Ashikari M, Ozeki H, Tomida K, Sakurai E, Tamai K, Ogura Y. Retention of dye after indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol
. 2003;136:172–174.
[CrossRef] [PubMed]Ho JD, Chen H-C, Chen S-N, Tsai RJ-F. Cytotoxicity of indocyanine green on retinal pigment epithelium: implications for macular hole surgery. Arch Ophthalmol
. 2003;121:1423–1429.
[CrossRef] [PubMed]Dietz FB, Jaffe RA. Indocyanine green: evidence of neurotoxicity in spinal root axons. Anesthesiology
. 2003;98:516–520.
[CrossRef] [PubMed]Iriyama A, Uchida S, Yanagi Y, et al. Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci
. 2004;45:943–947.
[CrossRef] [PubMed]